摘要
程序性死亡分子1(programmed death-1,PD1)及其配体(programmed death ligand,PDL)属于B7家族的共刺激分子,介导免疫反应的负性调节信号,在肿瘤发生、病毒感染以及自身免疫病中都发挥了特异性的调节作用。利用PD1/PDL1信号途径调节机体的免疫应答从而达到免疫治疗的目的,该文就此展开综述。
PD1(programmed death-1,PD1)and PDL1(programmed death ligand-1,PDL1) are members of co-stimulating molecules of B7 superfamily.PDL1 binds to PD-1,which mainly expresses on the activated T cells,mediates the negative modulating signals.Interfering the PD1/PDL signal pathway regulates the immunological responses,which could be used as a therapeutic strategy for cancer,viral infection and auto-immune diseases.In this paper,we reviewed the current progress of the associated research.
出处
《生命科学》
CSCD
北大核心
2011年第1期86-89,共4页
Chinese Bulletin of Life Sciences
基金
湖北省自然科学基金项目(2008CDB118)